jrnl4736

Publication Venue For

  • Vascular Consequences of Hyperuricemia and Hypouricemia.  45:453-464. 2019
  • Digital Interventions to Build a Patient Registry for Rheumatology Research.  45:173-186. 2019
  • The Interface Between Digital Health and Rheumatology.  45:xv-xvi. 2019
  • Tools and Methods for Real-World Evidence Generation: Pragmatic Trials, Electronic Consent, and Data Linkages.  45:275-289. 2019
  • Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective.  45:39-51. 2019
  • Genomics in Rheumatic Diseases: Hope for the Future.  43:xv-xvi. 2017
  • Integrative Approaches to Understanding the Pathogenic Role of Genetic Variation in Rheumatic Diseases.  43:449-466. 2017
  • Opportunistic Infections in Biological Therapy, Risk and Prevention.  43:27-41. 2017
  • Glucocorticoid-induced Osteoporosis.  42:177-189. 2016
  • Comorbidities in patients with crystal diseases and hyperuricemia.  40:251-278. 2014
  • Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus.  40:433-454. 2014
  • Systemic lupus erythematosus and malignancies: A review article.  40:497-506. 2014
  • Treatment of Juvenile Idiopathic Arthritis in the Biologic Age.  39:751-766. 2013
  • Ultrasound and Treatment Algorithms of RA and JIA.  39:669-688. 2013
  • ANCA-associated vasculitis. Preface..  36. 2010
  • Diagnostic Approach to ANCA-associated Vasculitides.  36:491-506. 2010
  • The History of ANCA-associated Vasculitis.  36:439-446. 2010
  • Preface.  36:13. 2010
  • Developments in glucocorticoid therapy.  31:1-17. 2005
  • Infections in systemic connective tissue diseases: Systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis.  29:163-184. 2003
  • Calcium and vitamin D in osteoporosis.  27:101-130. 2001
  • Comorbidity in rheumatoid arthritis.  27:283-303. 2001
  • Pathogenesis of rheumatoid arthritis: Role of B lymphocytes.  27:335-353. 2001
  • Preface.  25. 1999
  • Psychological and behavioral approaches to pain management for patients with rheumatic disease.  25:215-232. 1999
  • Minocycline for the treatment of rheumatoid arthritis.  24:489-499. 1998
  • T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis.  24:641-650. 1998
  • Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery.  23:981-993. 1997
  • Epidemiology of rheumatoid arthritis.  21:589-604. 1995
  • Do nonimmunologically mediated pathways play a role in the pathogenesis of rheumatoid arthritis?.  19:107-122. 1993
  • Host factors in the pathogenesis of arthritis triggered by infectious organisms.  19:279-292. 1993
  • Nongonococcal bacterial arthritis.  19:311-331. 1993
  • Treatment. Corticosteroids and anti-inflammatory drugs.  14:203-221. 1988
  • Analysis of restriction fragment length polymorphisms in rheumatic diseases.  13:353-367. 1987
  • Immune complexes in the rheumatic diseases..  13:583-596. 1987
  • Lentivirus-induced arthritis. Chronic disease caused by a covert pathogen.  13:235-247. 1987